Literature DB >> 33942361

REPLY.

Binu V John1,2, Bassam Dahman3, Tamar H Taddei4,5, Cynthia Levy2, David E Kaplan6,7.   

Abstract

Entities:  

Year:  2021        PMID: 33942361      PMCID: PMC8463416          DOI: 10.1002/hep.31876

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  4 in total

1.  Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.

Authors:  Angela C Cheung; Willem J Lammers; Carla F Murillo Perez; Henk R van Buuren; Aliya Gulamhusein; Palak J Trivedi; Konstantinos N Lazaridis; Cyriel Y Ponsioen; Annarosa Floreani; Gideon M Hirschfield; Christophe Corpechot; Marlyn J Mayo; Pietro Invernizzi; Pier Maria Battezzati; Albert Parés; Frederik Nevens; Douglas Thorburn; Andrew L Mason; Marco Carbone; Kris V Kowdley; Tony Bruns; George N Dalekos; Nikolaos K Gatselis; Xavier Verhelst; Keith D Lindor; Ana Lleo; Raoul Poupon; Harry L A Janssen; Bettina E Hansen
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-04       Impact factor: 11.382

2.  Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis.

Authors:  Binu V John; Gabriella Aitcheson; Kaley B Schwartz; Nidah S Khakoo; Bassam Dahman; Yangyang Deng; David Goldberg; Paul Martin; Tamar H Taddei; Cynthia Levy; David E Kaplan
Journal:  Hepatology       Date:  2021-05-26       Impact factor: 17.425

3.  Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver-Related Mortality Is Higher in Males?

Authors:  Ana Lleo; Gideon M Hirschfield
Journal:  Hepatology       Date:  2021-06-10       Impact factor: 17.425

4.  Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.

Authors:  Ana Lleo; Peter Jepsen; Emanuela Morenghi; Marco Carbone; Luca Moroni; Pier Maria Battezzati; Mauro Podda; Ian R Mackay; M Eric Gershwin; Pietro Invernizzi
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.